SYHX2005
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 08, 2022
A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=139 | Not yet recruiting | Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1